+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

ZD6474 prevents the formation of ductal hyperplasia, carcinoma in situ, and invasive tumors in the DMBA model of rat mammary carcinogenesis



ZD6474 prevents the formation of ductal hyperplasia, carcinoma in situ, and invasive tumors in the DMBA model of rat mammary carcinogenesis



Proceedings of the American Association for Cancer Research Annual Meeting 44: 1130




(PDF emailed within 1 workday: $29.90)

Accession: 036059921

Download citation: RISBibTeXText


Related references

Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia. Molecular Imaging 10(5): 370-376, 2012

Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy. Applied Spectroscopy 71(2): 300-307, 2018

Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Anticancer Research 25(3a): 1719-1723, 2005

Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: An immunohistochemical study. Virchows Archiv 424(5): 491-494, 1994

P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma. Journal of the Egyptian National Cancer Institute 19(3): 202-210, 2007

Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. Journal of Pathology 184(4): 396-400, 1998

Cell cycle proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. Journal of Pathology 181(SUPPL ): 21A, 1997

Gynecomastia With Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Associated With Invasive Breast Carcinoma in a Male Patient on Antiretroviral Therapy: A Case Report. International Journal of Surgical Pathology 24(2): 139-141, 2016

Atypical ductal hyperplasia and ductal carcinoma in situ associated with mucocele-like tumors of the breast. Modern Pathology 8(1): 15A, 1995

Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes. Journal of Cancer Research and Clinical Oncology 2019, 2019

The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification. Breast Cancer Research 5(5): 254-257, 2003

Estetrol prevents and suppresses mammary tumors induced by DMBA in a rat model. Hormone Molecular Biology and Clinical Investigation 9(1): 95-103, 2012

Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ. Archives of Pathology and Laboratory Medicine 140(7): 686-689, 2017

Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. Journal of Pathology 198(4): 458-467, 2002

HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry. Histopathology 48(6): 702-707, 2006